ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma - Quiz - MDSpire

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma

  • By

  • Xiaohong Yi

  • Xianwen Zhang

  • Lijun Huang

  • Yuhui Chen

  • Maochun You

  • Hongyi Jia

  • Lefeng Hou

  • Chao Hu

  • Kun Huang

  • Yumei Wang

  • June 2, 2026

Share

Original Source(s)

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma

  • by Xiaohong Yi, Xianwen Zhang, Lijun Huang, Yuhui Chen, Maochun You, Hongyi Jia, Lefeng Hou, Chao Hu, Kun Huang, Yumei Wang

  • June 2, 2026

Related Content

Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: a case report

The trinity of T cell engagement: navigating the molecular and clinical landscape of CAR-T, TILs, and TCEs in the war against cancer

Clinical heterogeneity and treatment optimization in anti-KLHL11 encephalitis: two case reports and literature review